Latest Articles

Publication Date
All News Scientific
Recent Trends in Medical Management of Endometriosis.

Endometriosis affects about 10 percent women in the reproductive age group globally and approximately 42 million in India. Managing the patient's pain symptoms associated with endometriosis appears to be the …

Published: Dec. 26, 2024, midnight
Read Full Article
Dienogest Elagolix Endometriosis-associated pain Hormone therapy endometriosis Medical management of endometriosis Medical therapy endometriosis Oral GnRH antagonist
Healthy Ideas Awarded Funding Through NHMRC Program - Mirage News

Healthy Ideas Awarded Funding Through NHMRC Program Mirage News

Published: Dec. 17, 2024, 5:38 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer - StockTitan

IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer StockTitan

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Larger Waistline May Not Be Always Bad: Know Ideal Waist Size If You've Diabetes - Medical Daily

Larger Waistline May Not Be Always Bad: Know Ideal Waist Size If You've Diabetes Medical Daily

Published: Dec. 6, 2024, 7:47 a.m.
Read Full Article
Grad students pitch impactful ideas to drive real change - Brighter World

Grad students pitch impactful ideas to drive real change Brighter World

Published: Dec. 4, 2024, 5:34 p.m.
Read Full Article
AURKA inhibits the decidualization of the eutopic endometrium in endometriosis through NF-κB p65†.

Endometriosis is an estrogen dependent disease, which is related to infertility. Decidualization is a prerequisite for successful implantation of human embryos, and endometriosis affects the occurrence of decidualization. However, the …

Published: Dec. 3, 2024, midnight
Read Full Article
Aurka decidualization endometriosis p65 phosphorylation
[Psychoemotional state and sexual function in women with chronic pelvic pain in genital endometriosis].

The purpose of this review is to consider current ideas about psychophysiology of chronic pelvic pain (CPP) in external genital endometriosis (GE), as well as the impact of the psychoemotional …

Published: Nov. 23, 2024, midnight
Read Full Article
biopsychosocial approach chronic pelvic pain dyspareunia genital endometriosis psychogenic risk factors sexual dysfunction
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!